<DOC>
	<DOC>NCT00760019</DOC>
	<brief_summary>The purpose of this study is to determine whether reducing inflammation in blood vessels with an aspirin-like drug called salsalate will improve blood vessel function.</brief_summary>
	<brief_title>Inflammation and Vascular Function in Atherosclerosis</brief_title>
	<detailed_description>To test the hypothesis that inhibition of I [kappa] B kinase [beta] (IĸKβ), an inflammatory mediator, by high dose salsalate, will restore insulin-mediated endothelium-dependent vasodilation in subjects with atherosclerosis.</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Salicylsalicylic acid</mesh_term>
	<mesh_term>Sodium Salicylate</mesh_term>
	<criteria>Nonsmoking adult subjects with known atherosclerosis Uncontrolled hypertension (&gt; 140/90 mmHg) Untreated hypercholesterolemia (LDL &gt; 160 mg/dL) Diabetes mellitus Alanine Aminotransferase &gt; 150 Creatinine &gt; 1.4 mg/dL Concommitant use of warfarin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>vascular inflammation</keyword>
	<keyword>endothelium-dependent flow-mediated blood vessel function</keyword>
</DOC>